Drug Pipeline Success: Positive clinical trial results or FDA approvals for Merck's drugs typically drive the stock price higher. Failures can have the opposite effect.

Competitor Activity: Actions from competing pharmaceutical companies, such as new drug launches or patent challenges, can impact Merck's market share and therefore its stock value.

Economic Conditions: Overall economic health and interest rates can influence investor sentiment towards pharmaceutical stocks, affecting investment decisions in MRK.US.

Patent Expirations: Loss of exclusivity for key drugs due to patent expirations can lead to generic competition and reduced revenue, potentially lowering the stock price.

Regulatory Environment: Changes in government regulations, healthcare policies, or pricing controls can impact Merck's profitability and its stock price.

Global Health Crises: Pandemics or other major health events can create increased demand for certain Merck products, impacting sales and the stock price.